Agios to Webcast Conference Call of Third Quarter 2020 Financial Results on November 5, 2020
October 22 2020 - 7:00AM
Agios Pharmaceuticals, Inc. (NASDAQ: AGIO), a leader in the field
of cellular metabolism to treat cancer and rare genetic diseases,
today announced that the company will host a conference call and
live webcast on Thursday, November 5, 2020 at 8:00 a.m. ET to
report its third quarter 2020 financial results and other business
highlights.
A live webcast can be accessed under "Events &
Presentations" in the Investors section of the company's website at
www.agios.com. The conference call can be accessed by dialing
1-877-377-7098 (domestic) or 1-631-291-4547 (international) and
referring to conference ID 7578909. The webcast will be archived
and made available for replay on the company's website beginning
approximately two hours after the event.
About AgiosAgios is focused on discovering and
developing novel investigational medicines to treat malignant
hematology, solid tumors and rare genetic diseases through
scientific leadership in the field of cellular metabolism. In
addition to an active research and discovery pipeline across these
three therapeutic areas, Agios has two approved oncology precision
medicines and multiple first-in-class investigational therapies in
clinical and/or preclinical development. For more information,
please visit the company's website at www.agios.com.
Contacts
Investors:Holly Manning, 617-844-6630Director,
Investor RelationsHolly.Manning@agios.com
Media:Jessica Rennekamp, 857-209-3286Associate
Director, Corporate CommunicationsJessica.Rennekamp@agios.com
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Aug 2024 to Sep 2024
Agios Pharmaceuticals (NASDAQ:AGIO)
Historical Stock Chart
From Sep 2023 to Sep 2024